These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12466756)

  • 1. Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation.
    Childs RW
    MedGenMed; 2002 Jun; 4(3):13. PubMed ID: 12466756
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
    Takahashi Y; Childs RW
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hemopoietic stem cell transplantation in solid tumors.
    Carnevale-Schianca F; Ricchiardi A; Capaldi A; Bucci AR; Grignani G; Rota-Scalabrini D; Fizzotti M; Aliberti S; Aglietta M
    Transplant Proc; 2005; 37(6):2664-6. PubMed ID: 16182778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.
    Arya M; Chao D; Patel HR
    Nat Clin Pract Oncol; 2004 Nov; 1(1):32-8. PubMed ID: 16264797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-myeloablative allogeneic hematopoietic stem cell transplants.
    Fagioli F; Ricchiardi A; Carnevale-Schianca F
    Haematologica; 2002 Aug; 87(8 Suppl):13-9. PubMed ID: 12412384
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
    Nakagawa T; Kami M; Hori A; Kim SW; Murashige N; Hamaki T; Kishi Y; Fujimoto H; Matsuoka N; Okajima E; Komiyama M; Tobisu K; Wakayama T; Uike N; Tajima K; Makimoto A; Mori S; Tanosaki R; Takaue Y; Kakizoe T
    Exp Hematol; 2004 Jul; 32(7):599-606. PubMed ID: 15246155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation.
    Schulenburg A; Turetschek K; Wrba F; Vogelsang H; Greinix HT; Keil F; Mitterbauer M; Kalhs P
    Ann Hematol; 2004 Feb; 83(2):101-6. PubMed ID: 14615909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment?
    Roigas J; Massenkeil G
    World J Urol; 2005 Jul; 23(3):213-20. PubMed ID: 15685446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.
    Massenkeil G; Roigas J; Nagy M; Wille A; Stroszczynski C; Mapara MY; Loening S; Dörken B; Arnold R
    Bone Marrow Transplant; 2004 Aug; 34(4):309-16. PubMed ID: 15220955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy.
    Ueno NT; Cheng YC
    Bone Marrow Transplant; 2006 Dec; 38(11):711-4. PubMed ID: 17106451
    [No Abstract]   [Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation for patients with metastatic renal cell carcinoma.
    Roigas J; Johannsen M; Ringsdorf M; Massenkeil G
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1449-58. PubMed ID: 17069529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's new in the treatment of metastatic kidney cancer?
    Mancuso A; Sternberg CN
    BJU Int; 2005 Jun; 95(9):1171-80. PubMed ID: 15892796
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
    Rini BI; Halabi S; Barrier R; Margolin KA; Avigan D; Logan T; Stadler WM; McCarthy PL; Linker CA; Small EJ; ; ;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):778-85. PubMed ID: 16785067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.
    Peccatori J; Barkholt L; Demirer T; Sormani MP; Bruzzi P; Ciceri F; Zambelli A; Da Prada GA; Pedrazzoli P; Siena S; Massenkeil G; Martino R; Lenhoff S; Corradini P; Rosti G; Ringden O; Bregni M; Niederwieser D;
    Cancer; 2005 Nov; 104(10):2099-103. PubMed ID: 16220555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.
    Demirer T; Barkholt L; Blaise D; Pedrazzoli P; Aglietta M; Carella AM; Bay JO; Arpaci F; Rosti G; Gurman G; Niederwieser D; Bregni M;
    Nat Clin Pract Oncol; 2008 May; 5(5):256-67. PubMed ID: 18398414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
    Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
    Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem-cell transplantation in renal-cell carcinoma.
    Hayes-Lattin BM; Maziarz RT; Beer TM
    Curr Oncol Rep; 2001 Sep; 3(5):433-7. PubMed ID: 11489245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmyeloablative allogeneic hematopoietic cell transplants: any role for rheumatoid arthritis?
    McSweeney P
    J Rheumatol Suppl; 2001 Oct; 64():49-54. PubMed ID: 11642505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.